Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9844925rdf:typepubmed:Citationlld:pubmed
pubmed-article:9844925lifeskim:mentionsumls-concept:C0600432lld:lifeskim
pubmed-article:9844925lifeskim:mentionsumls-concept:C0441471lld:lifeskim
pubmed-article:9844925lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:9844925lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:9844925lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:9844925lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:9844925lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:9844925lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:9844925pubmed:issue12lld:pubmed
pubmed-article:9844925pubmed:dateCreated1998-12-10lld:pubmed
pubmed-article:9844925pubmed:abstractTextErythroid and megakaryocyte lineages are closely linked and may share a common bipotent progenitor. However, the mechanisms associated with cell lineage commitment are not fully understood. The K562 erythroleukemia cell line serves as a model to study the biochemical changes associated with erythroid and megakaryocyte (E/M) differentiation. We have previously established that PMA-induced megakaryocyte differentiation of K562 cells requires the activity of the MEK/MAPK pathway (Herrera et al Exp Cell Res 1998; 238: 407-414). Here, we show that the PMA-induced phenotypic changes of K562 cells such as polylobulation of the nucleus and Pyk2 expression are independent of MAPK activation. In addition, we also demonstrate that inhibition of the basal activity of the extracellular regulated kinase (ERK/MAPK) pathway enhances the erythroid phenotype of these cells. These results suggest that the MAPK pathway regulates the E/M lineage commitment of K562 cells.lld:pubmed
pubmed-article:9844925pubmed:languageenglld:pubmed
pubmed-article:9844925pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:citationSubsetIMlld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844925pubmed:statusMEDLINElld:pubmed
pubmed-article:9844925pubmed:monthDeclld:pubmed
pubmed-article:9844925pubmed:issn0887-6924lld:pubmed
pubmed-article:9844925pubmed:authorpubmed-author:HerreraRRlld:pubmed
pubmed-article:9844925pubmed:authorpubmed-author:PetruzzelliLLlld:pubmed
pubmed-article:9844925pubmed:authorpubmed-author:ShellyCClld:pubmed
pubmed-article:9844925pubmed:issnTypePrintlld:pubmed
pubmed-article:9844925pubmed:volume12lld:pubmed
pubmed-article:9844925pubmed:ownerNLMlld:pubmed
pubmed-article:9844925pubmed:authorsCompleteYlld:pubmed
pubmed-article:9844925pubmed:pagination1951-61lld:pubmed
pubmed-article:9844925pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:meshHeadingpubmed-meshheading:9844925-...lld:pubmed
pubmed-article:9844925pubmed:year1998lld:pubmed
pubmed-article:9844925pubmed:articleTitlePMA-induced phenotypic changes in K562 cells: MAPK-dependent and -independent events.lld:pubmed
pubmed-article:9844925pubmed:affiliationDepartment of Cell Biology, Parke-Davis Pharmaceutical Research Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA.lld:pubmed
pubmed-article:9844925pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9844925pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9844925pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:9844925pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9844925lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9844925lld:pubmed